NCT01072097View on ClinicalTrials.gov

The Effect of Atorvastatin on Androgens, Glucose Metabolism and Inflammation in Polycystic Ovary Syndrome (PCOS) Women

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Atorvastatin

Atorvastatin 20mg/day for 6 months

DRUG

Placebo

Placebo for 6 months

Trial Locations (1)

90014

Department of Obstetrics and Gynaecology, University of Oulu, Oulu

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Oulu

OTHER